share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144：拟议出售证券
SEC announcement ·  04/02 16:38
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Mark E. Dmytruk is set to sell 51,169 Class A shares on April 2, 2024, with an aggregate market value of $53,667.78. The shares were acquired on April 1, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a three-month period where Dmytruk sold a total of 124,189 shares, generating gross proceeds of $167,121.55.
Ginkgo Bioworks Holdings, Inc. officer Mark E. Dmytruk is set to sell 51,169 Class A shares on April 2, 2024, with an aggregate market value of $53,667.78. The shares were acquired on April 1, 2024, as part of a restricted stock vesting and are considered compensation from the issuer. This transaction follows a three-month period where Dmytruk sold a total of 124,189 shares, generating gross proceeds of $167,121.55.
Ginkgo Bioworks Holdings, Inc.高管马克·德米特鲁克定于2024年4月2日出售51,169股A类股票，总市值为53,667.78美元。这些股票于2024年4月1日作为限制性股票归属的一部分被收购，被视为发行人的补偿。该交易是在三个月内Dmytruk共出售了124,189股股票之后进行的，总收益为167,121.55美元。
Ginkgo Bioworks Holdings, Inc.高管马克·德米特鲁克定于2024年4月2日出售51,169股A类股票，总市值为53,667.78美元。这些股票于2024年4月1日作为限制性股票归属的一部分被收购，被视为发行人的补偿。该交易是在三个月内Dmytruk共出售了124,189股股票之后进行的，总收益为167,121.55美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息